Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BCC Research | PRODUCT CODE: 2093461

Cover Image

PUBLISHER: BCC Research | PRODUCT CODE: 2093461

Global HLA Typing for Transplant Market

PUBLISHED:
PAGES: 85 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2950
PDF (2-5 Users)
USD 3540
PDF (Site License)
USD 4248
PDF (Enterprise License)
USD 5100

Add to Cart

This report analyzes the global HLA typing for transplant market, covering market size, growth trends, industry dynamics, emerging technologies, and competitive developments. The market is segmented by product and service type, technology, application, end user, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study includes insights into key applications such as solid organ and hematopoietic stem cell transplants, along with profiles of leading companies and forecasts through 2030.

Report Scope

The scope of the global HLA typing for transplant market study encompasses market size analysis, along with a detailed examination of market dynamics, emerging technologies, industry structure, and trends driving market growth. The market has been segmented based on product type, technology, application, end user, and region.

The report provides an overview of the global HLA typing for transplant market and examines market trends. It includes global revenue ($ million) for the base year 2024 and estimated data for the forecast period 2025 through 2030. Based on product and service type, the market is segmented into instruments, consumables, and services. Based on technology, the market is segmented into nonmolecular and molecular assays. Applications of HLA typing include solid-organ and hematopoietic stem cell transplants. Based on end user, the market is classified into hospitals and transplant centers, diagnostic laboratories, and research institutions. The report also focuses on the regional segmentation of the market. The regions covered in this study include North America, Europe, Asia-Pacific, and the rest of the world, with a focus on major countries in each region.

The report concludes with an analysis of the competitive landscape. It also has a dedicated section of company profiles that covers details of leading key market companies.

Report Includes

  • An overview and analysis of the global market for HLA typing for transplant
  • Analyses of global market trends, with revenue data for 2024, estimates for 2025, and projections of CAGRs through 2030
  • Estimates of the current market size and revenue growth prospects for the global market, along with a market share analysis by technology, product and service type, application and end user
  • Facts and figures related to market dynamics, including drivers, restraints and opportunities
  • Insights derived from Porter's Five Forces model and analysis of macroeconomic factors influencing the market
  • Review of the regulatory landscape affecting HLA typing for transplant
  • Discussion of emerging technologies, newest technology trends and developments in HLA typing
  • Competitive intelligence including industry structure, company share analysis and strategic developments
  • Profiles of leading companies operating in the global HLA typing for transplant market
Product Code: BIO277A

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion

Chapter 2 Market Overview

  • Overview
  • Classification of HLA Systems
  • HLA Typing in Transplantation
  • Porter's Five Forces Analysis
  • Potential of New Entrants (Moderate)
  • Bargaining Power of Suppliers (Low to Moderate)
  • Bargaining Power of Buyers (High)
  • Threat of Substitute Products (Low)
  • Industry Rivalry (High)
  • Macroeconomic Factors Analysis
  • Healthcare Budget Priorities
  • Geopolitical Factors
  • Tariffs' Impact on HLA Typing for Transplant Market

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Increasing Demand for Solid Organ Transplants
  • Growing Prevalence of Blood Cancers
  • Market Restraints
  • Demand and Supply Gaps in Organ Donations
  • High Equipment and Testing Costs
  • Market Opportunities
  • Growing Focus on Precision Transplantation Procedures
  • Expansion of Donor Registries

Chapter 4 Regulatory Landscape

  • Regulatory Aspects of HLA Typing for Transplant
  • U.S.
  • Europe
  • Asia-Pacific

Chapter 5 Emerging Technologies

  • Key Takeaways
  • Emerging Technologies
  • Next-Generation Sequencing (NGS)-Based HLA Typing
  • Eplet Matching Compatibility Analysis
  • AI-Driven Bioinformatics
  • Long-Read Sequencing Technologies for HLA Typing

Chapter 6 Market Segment Analysis

  • Segmentation Breakdown
  • Global HLA Typing for Transplant Market, by Product and Service Type
  • Key Takeaways
  • Consumables
  • Instruments
  • Services
  • Global HLA Typing for Transplant Market, by Technology
  • Key Takeaways
  • Molecular Technologies
  • Nonmolecular Technologies
  • Global HLA Typing for Transplant Market, by Application
  • Key Takeaways
  • Solid Organ Transplant
  • Stem Cell Transplant
  • Global HLA Typing for Transplant Market, by End User
  • Key Takeaways
  • Hospitals and Transplant Centers
  • Diagnostic Laboratories
  • Research Institutions
  • Geographic Breakdown
  • Global HLA Typing for Transplant Market, by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Company Share Analysis
  • Strategic Analysis

Chapter 8 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • BD
  • BIO-RAD LABORATORIES INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • OXFORD NANOPORE TECHNOLOGIES PLC.
  • PACBIO
  • QIAGEN
  • REVVITY
  • THERMO FISHER SCIENTIFIC INC.
  • A Few Emerging Start-ups/Market Disruptors
Product Code: BIO277A

List of Tables

  • Summary Table : Global HLA Typing for Transplant Market, by Region, Through 2030
  • Table 1 : Comparison of HLA Testing Techniques
  • Table 2 : Comparison of HLA Systems
  • Table 3 : Number of Global Solid Organ Transplants, 2024
  • Table 4 : Estimated New Blood Cancer Cases and Deaths in the U.S., 2025
  • Table 5 : Global HLA Typing for Transplant Market, by Product and Service Type, Through 2030
  • Table 6 : Global HLA Typing for Transplant Market for Consumables, by Region, Through 2030
  • Table 7 : Global HLA Typing for Transplant Market for Instruments, by Region, Through 2030
  • Table 8 : Global HLA Typing for Transplant Market for Services, by Region, Through 2030
  • Table 9 : Global HLA Typing for Transplant Market, by Technology, Through 2030
  • Table 10 : Global HLA Typing for Transplant Market for Molecular Technologies, by Region, Through 2030
  • Table 11 : Global HLA Typing for Transplant Market for Nonmolecular Technologies, by Region, Through 2030
  • Table 12 : Global HLA Typing for Transplant Market, by Application, Through 2030
  • Table 13 : Global HLA Typing for Transplant Market for Solid Organ Transplant, by Region, Through 2030
  • Table 14 : Global HLA Typing for Transplant Market for Stem Cell Transplant, by Region, Through 2030
  • Table 15 : Global HLA Typing for Transplant Market, by End User, Through 2030
  • Table 16 : Global HLA Typing for Transplant Market for Hospitals and Transplant Centers, by Region, Through 2030
  • Table 17 : Global HLA Typing for Transplant Market for Diagnostic Laboratories, by Region, Through 2030
  • Table 18 : Global HLA Typing for Transplant Market for Research Institutions, by Region, Through 2030
  • Table 19 : Global HLA Typing for Transplant Market, by Region, Through 2030
  • Table 20 : North American HLA Typing for Transplant Market, by Product and Service Type, Through 2030
  • Table 21 : North American HLA Typing for Transplant Market, by Technology, Through 2030
  • Table 22 : North American HLA Typing for Transplant Market, by Application, Through 2030
  • Table 23 : North American HLA Typing for Transplant Market, by End User, Through 2030
  • Table 24 : North American HLA Typing for Transplant Market, by Country, Through 2030
  • Table 25 : European HLA Typing for Transplant Market, by Product and Service Type, Through 2030
  • Table 26 : European HLA Typing for Transplant Market, by Technology, Through 2030
  • Table 27 : European HLA Typing for Transplant Market, by Application, Through 2030
  • Table 28 : European HLA Typing for Transplant Market, by End User, Through 2030
  • Table 29 : European HLA Typing for Transplant Market, by Country, Through 2030
  • Table 30 : Asia-Pacific HLA Typing for Transplant Market, by Product and Service Type, Through 2030
  • Table 31 : Asia-Pacific HLA Typing for Transplant Market, by Technology, Through 2030
  • Table 32 : Asia-Pacific HLA Typing for Transplant Market, by Application, Through 2030
  • Table 33 : Asia-Pacific HLA Typing for Transplant Market, by End User, Through 2030
  • Table 34 : Asia-Pacific HLA Typing for Transplant Market, by Country, Through 2030
  • Table 35 : RoW HLA Typing for Transplant Market, by Product and Service Type, Through 2030
  • Table 36 : RoW HLA Typing for Transplant Market, by Technology, Through 2030
  • Table 37 : RoW HLA Typing for Transplant Market, by Application, Through 2030
  • Table 38 : RoW HLA Typing for Transplant Market, by End User, Through 2030
  • Table 39 : RoW HLA Typing for Transplant Market, by Sub-Region, Through 2030
  • Table 40 : Recent Developments in HLA Typing for Transplant Market, 2023-2025
  • Table 41 : Abbreviations Used in the Global HLA Typing for Transplant Market
  • Table 42 : Information Sources for this Report
  • Table 43 : Agilent Technologies Inc.: Company Snapshot
  • Table 44 : Agilent Technologies Inc.: Financial Performance, FY 2024 and 2025
  • Table 45 : Agilent Technologies Inc.: Product Portfolio
  • Table 46 : Agilent Technologies Inc.: News/Key Developments, 2024
  • Table 47 : BD: Company Snapshot
  • Table 48 : BD: Financial Performance, FY 2024 and 2025
  • Table 49 : BD: Product Portfolio
  • Table 50 : BD: News/Key Developments, 2025
  • Table 51 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 52 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
  • Table 53 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 54 : Bio-Rad Laboratories Inc.: News/Key Developments, 2025
  • Table 55 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 56 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
  • Table 57 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 58 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024-2025
  • Table 59 : Illumina Inc.: Company Snapshot
  • Table 60 : Illumina Inc.: Financial Performance, FY 2023 and 2024
  • Table 61 : Illumina Inc.: Product Portfolio
  • Table 62 : Illumina Inc.: News/Key Developments, 2025
  • Table 63 : Oxford Nanopore Technologies plc.: Company Snapshot
  • Table 64 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2023 and 2024
  • Table 65 : Oxford Nanopore Technologies plc.: Product Portfolio
  • Table 66 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024-2025
  • Table 67 : PacBio: Company Snapshot
  • Table 68 : PacBio: Financial Performance, FY 2023 and 2024
  • Table 69 : PacBio: Product Portfolio
  • Table 70 : PacBio: News/Key Developments, 2025
  • Table 71 : Qiagen: Company Snapshot
  • Table 72 : Qiagen: Financial Performance, FY 2023 and 2024
  • Table 73 : Qiagen: Product Portfolio
  • Table 74 : Qiagen: News/Key Developments, 2025
  • Table 75 : Revvity: Company Snapshot
  • Table 76 : Revvity: Financial Performance, FY 2023 and 2024
  • Table 77 : Revvity: Product Portfolio
  • Table 78 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 79 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
  • Table 80 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 81 : Thermo Fisher Scientific Inc.: News/Key Developments, 2025
  • Table 82 : List of a Few Emerging Startups/Market Disruptors

List of Figures

  • Summary Figure : Global Market Shares of HLA Typing for Transplant, by Region, 2024
  • Figure 1 : Porter's Five Forces Analysis of the Global HLA Typing for Transplant Market
  • Figure 2 : Market Dynamics of HLA Typing for Transplant Market
  • Figure 3 : Advantages of NGS-Based HLA Typing
  • Figure 4 : Global Market Shares of HLA Typing for Transplant, by Product and Service Type, 2024
  • Figure 5 : Global Market Shares of HLA Typing for Transplant, by Technology, 2024
  • Figure 6 : Global Market Shares of HLA Typing for Transplant, by Application, 2024
  • Figure 7 : Global Market Shares of HLA Typing for Transplant, by End User, 2024
  • Figure 8 : Global Market Shares of HLA Typing for Transplant, by Region, 2024
  • Figure 9 : North American Market Shares of HLA Typing Market for Transplant, by Country, 2024
  • Figure 10 : European Market Shares of HLA Typing Market for Transplant, by Country, 2024
  • Figure 11 : Asia-Pacific Market Shares of HLA Typing Market for Transplant, by Country, 2024
  • Figure 12 : RoW Market Shares of HLA Typing Market for Transplant, by Sub-region, 2024
  • Figure 13 : Company Shares of Market for HLA Typing for Transplant, 2024
  • Figure 14 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2025
  • Figure 15 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2025
  • Figure 16 : BD: Revenue Shares, by Business Unit, FY 2025
  • Figure 17 : BD: Revenue Shares, by Country/Region, FY 2025
  • Figure 18 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
  • Figure 19 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
  • Figure 20 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
  • Figure 21 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
  • Figure 22 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 23 : Oxford Nanopore Technologies plc.: Revenue Share, by Country/Region, FY 2024
  • Figure 24 : PacBio: Revenue Share, by Country/Region, FY 2024
  • Figure 25 : Qiagen: Revenue Share, by Business Unit, FY 2024
  • Figure 26 : Qiagen: Revenue Share, by Country/Region, FY 2024
  • Figure 27 : Revvity: Revenue Shares, by Business Unit, FY 2024
  • Figure 28 : Revvity: Revenue Shares, by Country/Region, FY 2024
  • Figure 29 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
  • Figure 30 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!